Form 4 for CL Colgate-Palmolive
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-04 · accession 0001225208-21-013673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-08 | 2021-11-04+ | CL | Wallace Noel R. | COB, Pres, CEO, Dir | M - OptEx | $68.98 | +252.8K | 339.7K | +291% | +$17.44M |
| DM | 2021-11-08 | 2021-11-04+ | CL | Wallace Noel R. | COB, Pres, CEO, Dir | S - Sale+OE | $77.27 | -245.2K | 239.7K | -51% | -$18.95M |
| DM | 2021-11-08 | 2021-11-04+ | CL | Wallace Noel R. | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -252.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | M | A | 152,809 | $68.98 | 384,899 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-05 | M | A | 100,000 | $68.98 | 339,699 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-05 | S | D | 100,000 | $77.40 | 239,699 | D | — | — | (F5) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $77.08 to $77.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-11-04 | S | D | 145,200 | $77.18 | 239,699 | D | — | — | (F3) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.89 to $77.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-11-04 | M | D | 152,809 | $0.00 | 100,000 | D | $68.98 · — to 2022-04-21 | 152,809 Common Stock | (F6) Option became exercisable in equal annual installments over three years beginning on the third anniversary of the April 21, 2016 grant date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-11-05 | M | D | 100,000 | $0.00 | 0 | D | $68.98 · — to 2022-04-21 | 100,000 Common Stock | (F6) Option became exercisable in equal annual installments over three years beginning on the third anniversary of the April 21, 2016 grant date. |